[Biomaterials engineering strategies for spinal cord regeneration: state of the art].

Traumatic spinal cord injuries are very serious burden for the organism of affected human population, and are more critical because mostly touching the young cluster of population. Physical, emotional and economic problems caused by traumatic spinal cord injuries as a general rule significantly limit the individual patient functionality and are burden for the society. The spinal cord has considerable lack of ability for spontaneous and functional regeneration, hence the spinal cord injury cause a solemn and frequently permanent disabilities. The pathophysiology of spinal cord injury is the results of sequential two phenomena, primary physical and biochemical secondary mechanisms of injury. After physical injury, the spinal cord undergoes a sequential progression in biochemical pathologic deviations increasing after injury, that are mutually deteriorating and cause further damage in the spinal cord. Consequently series of pathological processes lead to haemorrhage, oedema, neuronal necrosis, axonal fragmentation, demyelination of the remaining axons, and formation of ultimately cyst. Furthermore spinal cord injuries can immediately result in neural cells death and cause disruption of the blood supply to the site of the injury. The most important difference between peripheral and central nervous system is the fact that in the spinal cord the neuronal cell bodies are damaged, while in the peripheral nervous system only axons are injured. In the surroundings of the spinal cord, one of the major factors hampering regeneration is the glial scar expansion. The spreading of densely packed astrocytes on the site of injuries effectively inhibit axon growth through the nerve grow blocking. Glial scar, which consists mainly of overactive astrocytes and fibroblasts, as well as the presence of growth-inhibitor molecules such as chondroitin sulphate proteoglycans (derived from the breakdown of damaged nerve cells) form a physicochemical barrier for effective regenerating axons. The recent scientific progress in medicine, biology and biomaterials engineering, and predominantly in the fields of neurosurgery, cell culture and tissue engineering, creates the opportunity for the development of new therapies, which support healing of the effects of traumatic spinal cord injuries and prevent further neurodegenerative processes. The most promising effects so far have been obtained using well-designed polymer scaffold as structural support for axon regeneration combined with drug delivery system or therapeutic cell line and neurotrophic factors. This review article focuses on the application of selected biomaterials for the regeneration of traumatic spinal cord injuries. First, the basic anatomical structure of the spinal cord has been described. Then the injury and neurodegenerative mechanisms within the peripheral and central nervous system have been compared. The pathophysiology of the spinal cord damage has been referred to the current strategy of biomaterials engineering in experimental therapies supporting neuroregeneration processes. In the summary, the promising interdisciplinary therapeutic strategies aimed at the regeneration of the spinal cord have been highlighted.